Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Carducci

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|January 5, 2002
NCCN: New chemotherapeutic approaches to hormone refractory prostate cancerM A Carducci,
Urology|February 25, 2000
Adjuvant chemotherapy for T3 prostate cancer: not ready for prime timeM A Carducci
BJU International|April 26, 2000
The role of endothelin-1 and endothelin receptor antagonists in prostate cancerJ B Nelson, M A Carducci
Cancer Treatment and Research|January 1, 1996
Renal, bladder, and prostate cancers: gene therapyM A Carducci, J W Simons
Cancer Investigation|March 4, 2000
Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancerJ B Nelson, M A Carducci
Expert Opinion on Investigational Drugs|November 28, 2000
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitorsS D Gore, M A Carducci
Current Cancer Drug Targets|December 23, 2009
HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosidesJ Lin, S Denmeade, M A Carducci
Prostate Cancer and Prostatic Diseases|April 26, 2017
A review of pomegranate in prostate cancerC J Paller, A Pantuck, M A Carducci
International Journal of Oncology|April 29, 1998
Cytotoxic effects of sodium phenylbutyrate on human neuroblastoma cell linesM A Pelidis, M A Carducci, J W Simons
The Urologic Clinics of North America|June 11, 1999
Prostate-specific antigen and other markers of therapeutic responseM A Carducci, T L DeWeese, J B Nelson
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Cancer Control : Journal of the Moffitt Cancer Center|January 5, 2002
NCCN: New chemotherapeutic approaches to hormone refractory prostate cancerM A Carducci,
Urology|February 25, 2000
Adjuvant chemotherapy for T3 prostate cancer: not ready for prime timeM A Carducci
BJU International|April 26, 2000
The role of endothelin-1 and endothelin receptor antagonists in prostate cancerJ B Nelson, M A Carducci
Cancer Treatment and Research|January 1, 1996
Renal, bladder, and prostate cancers: gene therapyM A Carducci, J W Simons
Cancer Investigation|March 4, 2000
Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancerJ B Nelson, M A Carducci
Expert Opinion on Investigational Drugs|November 28, 2000
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitorsS D Gore, M A Carducci
Current Cancer Drug Targets|December 23, 2009
HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosidesJ Lin, S Denmeade, M A Carducci
Prostate Cancer and Prostatic Diseases|April 26, 2017
A review of pomegranate in prostate cancerC J Paller, A Pantuck, M A Carducci
International Journal of Oncology|April 29, 1998
Cytotoxic effects of sodium phenylbutyrate on human neuroblastoma cell linesM A Pelidis, M A Carducci, J W Simons
The Urologic Clinics of North America|June 11, 1999
Prostate-specific antigen and other markers of therapeutic responseM A Carducci, T L DeWeese, J B Nelson
Pageof 5